Genetic alterations of CCND1 and EMSY in breast cancers.
about
Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms.Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer CellsSynthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationInherited and acquired alterations in development of breast cancer.EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.The 11q13-q14 amplicon: clinicopathological correlations and potential drivers.The function of EMSY in cancer development.Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.Functional characterization of EMSY gene amplification in human cancers.EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.Identification of an aggressive prostate cancer predisposing variant at 11q13.Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
P2860
Q33889555-AD1EB6D8-B492-439A-85BF-B674522EFD94Q34487091-4F5534FD-0A72-4065-8E46-3CC813299363Q35051154-FE945946-9496-4969-88D7-34FFDDDC4347Q36147178-182C0596-B76B-4154-904D-25C9F0F0701AQ36925229-84BB0935-7029-4F9D-ACBB-7583354EE5C0Q37843728-79890264-D8B6-4A62-BA5A-92D64B819922Q38066149-32919455-F680-4387-98D6-4D14A2F82970Q38194481-28071F01-C691-4996-803D-AED5AC19DA52Q38416045-11D9F544-2F44-461C-A00D-10FB2004CA21Q39511351-63219297-5A1D-43DC-9592-F9D42A411877Q40581699-630D1CDE-F40E-4EAD-9720-5B6F95641111Q41111172-C10AC3C6-1395-49F9-AB64-F8215E447A04Q43684049-E732F67E-694C-418B-A81A-C48D60FE0266Q43909947-E60D8838-574C-4F7A-A372-3436D4643665Q54215084-4E850C20-8243-45D5-9D13-1B42B127857EQ55223470-95A30DFF-CDEB-4577-B1D4-936814BB38EC
P2860
Genetic alterations of CCND1 and EMSY in breast cancers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Genetic alterations of CCND1 and EMSY in breast cancers.
@en
Genetic alterations of CCND1 and EMSY in breast cancers.
@nl
type
label
Genetic alterations of CCND1 and EMSY in breast cancers.
@en
Genetic alterations of CCND1 and EMSY in breast cancers.
@nl
prefLabel
Genetic alterations of CCND1 and EMSY in breast cancers.
@en
Genetic alterations of CCND1 and EMSY in breast cancers.
@nl
P2093
P2860
P1433
P1476
Genetic alterations of CCND1 and EMSY in breast cancers.
@en
P2093
F M Campbell
J M S Bartlett
K V Nielsen
L B Jensen
T Kirkegaard
P2860
P304
P356
10.1111/J.1365-2559.2008.03007.X
P577
2008-04-02T00:00:00Z